EXODUS BIO  

EXODUS Bio is a pioneering biotechnology company transforming the future of drug delivery through our proprietary extracellular vesicle (EV)-based platform. With a mission to unlock the full therapeutic potential of biologics and nucleic acid-based therapies, EXODUS Bio harnesses the natural power of EVs to overcome the challenges of targeted delivery, safety, and efficiency across a broad range of indications. Our platform is designed to support the development of next-generation therapeutics, including RNA medicines, gene editing tools, and immunotherapies, by providing a safer and more effective alternative to traditional delivery vehicles.